MoneyWorks4Me

Hester Biosciences - Quaterly Results

07 Nov 2023 Evaluate
A decrease in the sales to Rs. 664.33 millions was observed for the quarter ended September 2023. The sales stood at Rs. 720.03 millions during the similar quarter previous year.Profit after Tax for the quarter ended September 2023 saw a decline of -34.44% from Rs. 103.45 millions to Rs. 67.82  millions.The Operating Profit of the company witnessed a decrease to 132.13 millions from 179.59 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 664.33 720.03 -7.74 1467.78 1225.31 19.79 2540.00 2193.51 15.80
Other Income 12.20 21.77 -43.96 20.79 34.11 -39.05 53.23 46.57 14.30
PBIDT 132.13 179.59 -26.43 254.37 283.91 -10.40 602.09 652.26 -7.69
Interest 14.75 17.43 -15.38 24.17 30.12 -19.75 64.97 24.68 163.25
PBDT 117.38 162.16 -27.61 230.20 253.79 -9.30 537.12 627.58 -14.41
Depreciation 25.78 23.37 10.31 51.26 47.30 8.37 97.88 95.02 3.01
PBT 91.60 138.79 -34.00 178.94 206.49 -13.34 439.24 532.56 -17.52
TAX 23.78 35.34 -32.71 46.41 52.99 -12.42 115.82 137.39 -15.70
Deferred Tax -1.06 0.10 -1160.00 -2.10 -2.42 -13.22 8.55 -5.14 -266.34
PAT 67.82 103.45 -34.44 132.53 153.50 -13.66 323.42 395.17 -18.16
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 19.89 24.94 -20.26 17.33 23.17 -25.21 23.70 29.74 -20.28
Peers
Company Name CMP
Sun Pharma. Inds. 1860.75
Dr. Reddys Labs. 1213.80
Cipla 1375.10
Lupin 2097.70
Zydus Lifesciences 1157.60
View more..